Research: Addressing cardiodiabesity at the household level could lower cost trend
Research suggests that combatting cardiodiabesity at the family and household level could further improve health outcomes and lower costs.
Read MoreEnhancing health outcomes and savings through value-based solutions
Patient engagement paired with cost-containment strategies drives better health outcomes and reduces the financial burden for plan sponsors.
Read MoreStudy: Progression of cardiodiabesity increases care utilization and costs
The Evernorth Research Institute’s latest cardiodiabesity report helps illustrate sites of care where preventive interventions can make the greatest financial impact.
Read MoreGLP-1s and digital support: A winning combination
When GLP-1s aren’t enough, lifestyle modification can be key to weight management.
Read MoreEasing the impact of GLP-1s
With GLP-1 sales forecast to exceed $100 billion, plan sponsors need the tools to control growth and expand access.
Read MoreChronic conditions: The impact of delayed detection
Early detection of chronic diseases matters to the bottom line.
Read More